Today's City Moves cover investments,finance and advisory and pharmaceuticals. Take a look at these movers and shakers:
Chartered Institute for Securities & Investment
Edward Loader has been appointed president of the Chartered Institute for Securities & Investment (CISI) Jersey branch. Loader is a co-founder and managing director of Integritas Wealth Partners. He is a chartered fellow of the Chartered Institute for Securities & Investment (CISI) and a member of the Society of Trust and Estate Practitioners (STEP). He holds a number of professional qualifications including the CISI Masters in wealth management and the STEP Diploma in international trust management. Edward has over 10 years of wealth management experience, working with private clients and intermediaries in developing investment and holistic wealth solutions. Before establishing Integritas Wealth Partners, his most recent role had been as a Director in the investments department of Royal Bank of Canada (RBC) Wealth Management, moving to Jersey in 2013 from RBC's London office.
Catalyst Corporate Finance
Catalyst Corporate Finance has appointed a new partner, Matthew Wiseman, to strengthen its consumer sector focus in the UK. Wiseman’s role will be to work closely with business owners and management teams in the personal care and beauty sector, as well as supporting financial sponsors, whether that be the generation of off-market opportunities, buy-side advice or maximising value in sales processes. The consumer team at Catalyst has recently completed transactions worth more than £1bn for clients operating across the sector including product owners, service providers and retail. Wiseman has over 15 years of M&A experience in branded consumer goods, having advised many multi-national and private owners of household, personal care and beauty assets globally and will bring considerable experience within the branded consumer goods space. He has advised on the sales of market-leading brands including Bulldog, Ren Skincare, Batiste Dry Shampoo and Liz Earle, as well as having worked with major global corporates including PZ Cussons and Henkel.
Ergomed, a London-listed company dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, has appointed Dan Weng as its new chief executive officer and a board director of Ergomed. Weng joins Ergomed with effect from 1 July 2017 from EPS Holdings, a global CRO listed on the Tokyo Stock Exchange. When Weng joins the company, Miroslav Reljanovic, Ergomed’s founder, will transition from CEO to executive vice-chairman, where he will support Weng and the board in providing strategic guidance on Ergomed’s co-development business and wholly-owned pipeline.
To appear in City Moves please email your career updates and pictures to email@example.com.